Ken Griffin Legend Biotech Corp Put Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$43.55 - $59.88 $727,285 - $999,996	-16,700 Reduced 45.14%	20,300 $989,000
Q2 2024 Aug 14, 2024	SELL	$39.5 - $57.22 $1.71 Million - $2.48 Million	-43,400 Reduced 53.98%	37,000 $1.64 Million
Q1 2024 May 15, 2024	BUY	$55.06 - $69.99 $3.43 Million - $4.36 Million	62,300 Added 344.2%	80,400 $4.51 Million
Q4 2023 Feb 14, 2024	BUY	$57.25 - $69.74 $349,225 - $425,413	6,100 Added 50.83%	18,100 $1.09 Million
Q3 2023 Nov 14, 2023	BUY	$63.16 - $76.5 $480,016 - $581,400	7,600 Added 172.73%	12,000 $806,000
Q2 2023 Aug 14, 2023	SELL	$46.28 - $75.01 $55,536 - $90,012	-1,200 Reduced 21.43%	4,400 $303,000
Q1 2023 May 15, 2023	SELL	$43.42 - $57.37 $521,040 - $688,440	-12,000 Reduced 68.18%	5,600 $270,000
Q4 2022 Feb 14, 2023	SELL	$38.8 - $55.46 $155,200 - $221,840	-4,000 Reduced 18.52%	17,600 $878,000
Q3 2022 Nov 14, 2022	SELL	$38.15 - $57.1 $274,680 - $411,120	-7,200 Reduced 25.0%	21,600 $881,000

226

74.5M

279K

350K

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $6.18B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.